Despite there being no distinguishable difference in the expression of the PD1 and tumor-infiltrating lymphocyte markers between HER2-amplified and non-amplified ICC groups, the characteristics of their tumor microenvironment remain unexplored. Here, ERBB2 is linked to intrahepatic cholangiocarcinoma.